Posted Oct. 20, 2004 at 5:58 p.m.

Premium Lock KBI's 'Centrifugal Bioreactor' Wins Huge Endorsement

Published: 2004-10-20 17:58:16
Updated: 2004-10-20 17:58:16


The proprietary means of creating proteins for use in biopharma products earns KIB Biopharma a $500,000 NSF Phase II grant -- and plenty of credibility. Other biotech, pharmaceutical firms are already calling about the technology....

Read More
Read More

Copyright 2014 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
The Skinny

The Skinny

WRAL TechWire Publisher and Editor Rick Smith dishes out tidbits from the local technology sector. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll